Centre of Chemistry of University of Minho (CQUM), Campus de Gualtar, Universidade do Minho, 4710-057 Braga, Portugal.
Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Avda de Barcelona, E-15782 Santiago de Compostela, Spain.
Molecules. 2024 May 28;29(11):2543. doi: 10.3390/molecules29112543.
A set of 2-aryl-9-H or methyl-6-morpholinopurine derivatives were synthesized and assayed through radioligand binding tests at human A, A, A, and A adenosine receptor subtypes. Eleven purines showed potent antagonism at A, A, dual A/A, A/A, or A/A adenosine receptors. Additionally, three compounds showed high affinity without selectivity for any specific adenosine receptor. The structure-activity relationships were made for this group of new compounds. The 9-methylpurine derivatives were generally less potent but more selective, and the 9H-purine derivatives were more potent but less selective. These compounds can be an important source of new biochemical tools and/or pharmacological drugs.
一套 2-芳基-9-H 或 6-吗啉基甲基嘌呤衍生物被合成,并通过放射性配体结合试验在人 A、A、A 和 A 腺苷受体亚型中进行了检测。11 种嘌呤在 A、A、双重 A/A、A/A 或 A/A 腺苷受体上表现出强拮抗作用。此外,三种化合物对任何特定的腺苷受体均表现出高亲和力而无选择性。对这组新化合物进行了构效关系研究。9-甲基嘌呤衍生物通常效力较低但选择性较高,而 9H-嘌呤衍生物则效力较高但选择性较低。这些化合物可以成为新的生化工具和/或药理学药物的重要来源。